United States · FDA National Drug Code directory
Metformin hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42291-825_42c9e096-bccc-ad6e-e063-6294a90a4e5e
- Product NDC
- 42291-825
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Metformin hydrochloride
- Labeler
- AvKARE
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240611
- Source listing expiry
- 20261231
Source-listed ingredients
- METFORMIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-825-10) · 42291-825-10
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-825-12) · 42291-825-12
- 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-825-18) · 42291-825-18
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-825-30) · 42291-825-30
- 360 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-825-36) · 42291-825-36
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-825-60) · 42291-825-60
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-825-90) · 42291-825-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →